---
title: "FDA drug chief may retire, adding to agency turmoil"
summary: "Richard Pazdur, head of the FDA’s drug review center, may step down after only a few weeks in the job. His possible exit comes as the agency is already in chaos, with several leaders leaving, lawsuits, and clashes over new fast‑track approval rules. Finding a new chief could be hard, and the rapid‑approval plan has barely begun. The uncertainty hurts confidence in the FDA and in drug development."
category: "Sports General News"
section: "US news"
imageUrl: "https://media.guim.co.uk/dbec8bc6d1fa1bd3c4d04c2fe910f9301a4332db/342_0_5600_4480/500.jpg"
publishedAt: "2025-12-03T14:04:48Z"
guardianId: "science/2025/dec/03/fda-drug-chief-signals-retires-pazdur"
---

Richard Pazdur, head of the FDA’s drug review center, may step down after only a few weeks in the job. His possible exit comes as the agency is already in chaos, with several leaders leaving, lawsuits, and clashes over new fast‑track approval rules. Finding a new chief could be hard, and the rapid‑approval plan has barely begun. The uncertainty hurts confidence in the FDA and in drug development.
